Underutilization or use of a suboptimal dose of an ACE inhibitor in patients with CHF seems common.13 Variables that could affect the use of optimal doses of an ACE inhibitor include both physician and patient-dependent factors. The gene discussed is ACE; the disease is congestive heart failure.